documents: FDA-2021-N-0874-0077
Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API
This data as json
| id | agency_id | docket_id | title | document_type | subtype | posted_date | posted_year | posted_month | comment_start_date | comment_end_date | last_modified | fr_doc_num | open_for_comment | withdrawn | object_id |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| FDA-2021-N-0874-0077 | FDA | FDA-2021-N-0874 | Letter from FDA OC Re Intarcia Therapeutics, Inc. Hearing Request for NDA 209053 ITCA 650 (exenatide in DUROS device) | Other | Letter(s) | 2023-04-28T04:00:00Z | 2023 | 4 | 2023-04-28T04:00:00Z | 2023-04-28T12:29:34Z | 0 | 0 | 090000648599a397 |
Links from other tables
- 0 rows from regs_document_id in fr_regs_crossref